The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30

Quality of Life Research

Volumn 5, Issue 6, 1996, Pages 555-567

  King, M T ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

cancer; clinical importance; effect size; interpretations; quality of life; statistical significance

Indexed keywords

ARTICLE; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AUSTRALIA; HUMANS; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SELF CONCEPT; SEVERITY OF ILLNESS INDEX;

EID: 0030471590     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00439229     Document Type: Article

References (35)

1. Editorial. Quality of life and clinical trials. Lancet 1995; 346: 1-2.
2. Osoba D. Lessons learned from measuring health-related quality if life in oncology. J Clin Oncol 1994; 12: 608-616.
3. Moinpour CM. Measuring quality of life: An emerging science. Sem Oncol 1994; 21: 48-63.
4. Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res 1993; 2: 221-226.
5. Cohen J. Statistical Power Analysis for the Behavioural Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988: 12,25.
6. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI 1993; 85: 365-376.
7. Aaronson NK, Cull A, Kaasa S, Sprangers MAG, EORTC Study Group on Quality of Life. The European Organisation for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: an update. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. New York: Raven Press, 1996.
8. Aaronson NK, Ahmedzai S, Bullinger M, et al. The EORTC core quality of life questionnaire: interim results of an international field study. In: Osoba D, ed. Effect of Cancer on Quality of Life. Boca Raton, FL: CRC, 1991: 185-203.
9. Bjordal K, Kaasa S. Psychometric validation of the EORTC core quality of life questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncologica 1992; 31: 311-321.
10. Ringdal GI, Ringdal K. Testing the EORTC quality of life questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 1993; 2: 129-140.
11. Ringdal GI, Ringdal K, Kvinnsland S, Gotestam KG. Quality of life of cancer patients with different prognoses. Qual Life Res 1994; 3: 143-154.
12. Fossa SD. Quality of life assessment in unselected oncologic out-patients: A pilot study. Int J Oncol 1994; 4: 1393-1397.
13. Bergman B, Sullivan M, Sorenson S. Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC core quality of life questionnaire and comparison with the Sickness Impact Profile. Acta Oncologica 1992; 31: 19-28.
14. Sigurdardottir V, Bolund C, Brandberg Y, Sullivan M. The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res 1993; 2: 193-203.
15. Bye A, Ose T, Kaasa S. Quality of life during pelvic radiotherapy. Acta Obstet Gynecol Scand 1995; 74: 147-152.
16. Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J. Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 1994; 3: 353-364.
17. Machin D, Campbell MJ. Statistical Tables for the Design of Clinical Trials. Oxford: Blackwell, 1987: 210
18. Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiation Oncol Biol Phys 1994; 28: 847-856.
19. King MT, Dobson AJ, Harnett PR. A comparison of two quality-of-life questionnaires for cancer clinical trials: the Functional Living Index - Cancer (FLIC) and the Quality of Life Questionnaire core module (QLQ-C30). J Clin Epidemiol 1995; 49: 21-29.
20. Blazeby JM, Williams MH, Brookes ST, Alderson D, Farndon JR. Quality of life measurement in patients with oespohageal cancer. Gut 1995; 37: 505-508.
21. Hjermstad M, Fossa SD, Bjordal K, Kaasa S. Test/retest study of the European Organisation for Research and Treatment of Cancer core quality-of-life questionnaire. J Clin Oncol 1995; 13: 1249-1254.
22. Moore MJ, Osoba D, Murphy K, et al. Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. J Clin Oncol 1994; 12: 689-694.
23. Hill M, Norman A, Cunningham D, Findlay M, Watson M, Nicolson V. Impact of protracted venous infusion fluorouracil with or without interferon alpha-b2 on tumour response, survival, and quality of life in advanced colorectal cancer. J Clin Oncol 1995; 13: 2317-2323.
24. Hopwood P, Stephens RJ, Machin D. Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 1994; 3: 339-352.
25. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993: 1:1-12:10.
26. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-415.
27. Guyatt GH, Feeny DH, Patrick DL. Proceedings of the international conference on the measurement of quality of life as an outcome in clinical trials: postscript. Control Clin Trials 1991; 12: 266S-269S.
28. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81-87.
29. Fowler FJ, Wennberg JE, Timothy RP, Barry MJ, Mulley AG, Hanley D. Symptom status and quality of life following prostatectomy. J Amer Med Assoc 1988; 259: 3018-3022.
30. O'Brien BJ, Drummond MF. Statistical versus quantitative significance in the socioeconomic evaluation of medicines. PharmacoEconomics 1994; 5: 389-398.
31. Kendall MG, Stuart A. The Advanced Theory of Statistics, Third Edition, Vol 2. Inference and Relationships. London: Griffin, 1973: 483-487.
32. Julious SA, George S, Campbell MJ. Sample sizes for studies using the short form 36 (SF-36). J Epidemiol Comm Health 1995; 49: 642-644.
33. Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995; 311: 1145-1148.
34. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston: Little, Brown, 1991: 3-435.
35. Fayers PM, Aaronson NK, Bjordal K, et al. EORTC QLQ-C30 Scoring Manual. Brussels: EORTC Study Group on Quality of Life, 1995.